Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Promyco Diagnostics
Israelou.edu ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Promyco Diagnostics has developed a simple and noninvasive serology-based diagnostic kit for the detection of urogenital mycoplasma infections. The product is designed to be easy to use and aims to improve the diagnosis of these infections, which are relevant in contexts such as high-risk pregnancies[1][2][3].
- Therapeutic areas
- Women's HealthInfectious Diseases
- Modalities
- DeviceDiagnostic kit
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Promyco Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Promyco Diagnostics.